Handelsbanken Fonder AB trimmed its holdings in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 2.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 51,700 shares of the company’s stock after selling 1,500 shares during the quarter. Handelsbanken Fonder AB’s holdings in DocuSign were worth $4,650,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Toronto Dominion Bank grew its position in shares of DocuSign by 30.3% in the third quarter. Toronto Dominion Bank now owns 26,159 shares of the company’s stock valued at $1,624,000 after purchasing an additional 6,081 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in DocuSign by 1.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company’s stock worth $82,478,000 after buying an additional 16,014 shares during the last quarter. International Assets Investment Management LLC increased its stake in DocuSign by 5,660.8% during the 3rd quarter. International Assets Investment Management LLC now owns 438,914 shares of the company’s stock worth $27,252,000 after buying an additional 431,295 shares in the last quarter. Quantinno Capital Management LP raised its holdings in shares of DocuSign by 39.5% during the third quarter. Quantinno Capital Management LP now owns 201,546 shares of the company’s stock valued at $12,514,000 after acquiring an additional 57,104 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. boosted its stake in shares of DocuSign by 7.1% in the third quarter. Robeco Institutional Asset Management B.V. now owns 1,296,517 shares of the company’s stock worth $80,501,000 after acquiring an additional 85,987 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.
DocuSign Price Performance
DocuSign stock opened at $83.96 on Monday. The firm has a 50 day simple moving average of $91.73 and a 200-day simple moving average of $76.87. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86. The stock has a market cap of $16.96 billion, a price-to-earnings ratio of 17.31, a price-to-earnings-growth ratio of 6.94 and a beta of 0.89.
Analyst Upgrades and Downgrades
Read Our Latest Stock Analysis on DOCU
Insider Activity
In related news, insider James P. Shaughnessy sold 7,500 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $90.17, for a total transaction of $676,275.00. Following the completion of the transaction, the insider now owns 43,781 shares of the company’s stock, valued at approximately $3,947,732.77. This trade represents a 14.63 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Teresa Briggs sold 534 shares of the stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $94.60, for a total transaction of $50,516.40. Following the transaction, the director now directly owns 7,736 shares of the company’s stock, valued at $731,825.60. The trade was a 6.46 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 693,773 shares of company stock valued at $66,727,926 in the last 90 days. Company insiders own 1.66% of the company’s stock.
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
- Five stocks we like better than DocuSign
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- 3 Best Fintech Stocks for a Portfolio Boost
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Stock Analyst Ratings and Canadian Analyst Ratings
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.